Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study.

Transl Lung Cancer Res · 2025 · PMC12541656 · PMID 41133009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a recent retrospective study on SMARCA4-related clinical cases, patients with high PD-L1 expression (≥50%) showed a trend toward better ICIs efficacy, but the difference was not statistically significant ( 20 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.